1-8 of 8
Lori A. Hazlehurst, Ph.D.
Close
Sort by
Journal Articles

PYK2 Mediates Microenvironment-Specific Myeloma Survival

Mark Meads, PhD, Bin Fang, PhD, Linda Mathews, Jennifer Gemmer, Liang Nong, M.D., Lori A Hazlehurst, Ph.D, Robert MacLeod, PhD, John Koomen, Ph.D., Kenneth Shain, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4443.
https://doi.org/10.1182/blood.V122.21.4443.4443
Published: 2013
Journal Articles

Bone Marrow Beta-Catenin Expression In Chronic Myelogenous Leukemia Patients Treated With Imatinib

Xiaohui Zhang, MD, Kendra L Sweet, MD, MS, Lynn Moscinski, MD, Lori A Hazlehurst, Ph.D, Javier Pinilla-Ibarz, MD, PhD, Ling Zhang, MD
Journal: Blood
Blood (2013) 122 (21): 2739.
https://doi.org/10.1182/blood.V122.21.2739.2739
Published: 2013
Journal Articles

Personalizing Myeloma Chemotherapy Using Evolutionary Computational Models and Ex Vivo Assays.

Ariosto Siqueira Silva, PhD, Zayar Khin, BSc, Kenneth H Shain, MD, Ph.D, Rachid Baz, MD, Lori A Hazlehurst, Ph.D, Ashley Durand, BSc, Robert Gatenby, MD
Journal: Blood
Blood (2012) 120 (21): 2960.
https://doi.org/10.1182/blood.V120.21.2960.2960
Published: 2012
Journal Articles

Mti-101 Induces Necrotic Cell Death in AML Cells Through Its Binding to Cell Surface Complexes Containing CD44 and ITGA4

Rajesh R Nair, Ph.D., Joel H Tolentino, PhD, Milijana Ugrenovic, BSc, Priyesh R Jain, Ph.D., Mark L McLaughlin, Ph.D., Jeffrey E Lancet, MD, Lori A Hazlehurst, Ph.D
Journal: Blood
Blood (2012) 120 (21): 869.
https://doi.org/10.1182/blood.V120.21.869.869
Published: 2012
Journal Articles

Mti-101 (cyclized HYD1) Binds to CD44 and Induces Necrotic Cell Death in Multiple Myeloma

Anthony W. Gebhard, M.S., Rajesh R Nair, Ph.D., Michael Emmons, Ph.D, Priyesh R Jain, Ph.D., Andreas Becker, Ph.D., John Koomen, Ph.D., Ernst Schonbrunn, Ph.D., Daniel M Sullivan, MD, Mark L McLaughlin, Ph.D., Lori A Hazlehurst, Ph.D
Journal: Blood
Blood (2012) 120 (21): 4022.
https://doi.org/10.1182/blood.V120.21.4022.4022
Published: 2012
Journal Articles

Prognostic Significance of VLA4 and CD44 Expression by Flow Cytometry in Multiple Myeloma (MM)

Wasif Riaz, MBBS, John Pham, Ling Zhang, MD, Lynn Moscinski, MD, Lori A Hazlehurst, Ph.D, Michael Emmons, Ph.D, Daniel M Sullivan, MD, Kenneth H Shain, MD, Ph.D, Conor Lynch, Ph.D, Yue Binglin, Hui-Yi Lin, Ph.D, Rachid Baz, MD
Journal: Blood
Blood (2012) 120 (21): 4975.
https://doi.org/10.1182/blood.V120.21.4975.4975
Published: 2012
Journal Articles

NF-kB as a Regulator of FA/BRCA Gene Expression in Multiple Myeloma.

Vasco A. Oliveira, PhD, Linda Mathews, B.Sc., Danielle Yarde, B.Sc, Xingyu Wang, Ph.D., David Boulware, M.Sc., Lori A. Hazlehurst, Ph.D., Dung-Tsa Chen, Ph.D., Amer Beg, Ph.D., William S. Dalton, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3508.
https://doi.org/10.1182/blood.V110.11.3508.3508
Published: 2007
Journal Articles

Bortezomib Enhances Melphalan Response by Altering Fanconi Anemia (FA)/BRCA Pathway Expression and Function.

Danielle N. Yarde, BS, Lori A. Hazlehurst, Ph.D., Vasco A. Oliveira, Ph.D., Qing Chen, Ph.D., William S. Dalton, Ph.D, M.D.
Journal: Blood
Blood (2006) 108 (11): 840.
https://doi.org/10.1182/blood.V108.11.840.840
Published: 2006